HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Funding Advice From FDA Science Board: Double Total Over Next Five Budgets

This article was originally published in The Tan Sheet

Executive Summary

FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following four federal budgets

You may also be interested in...



Enhanced FDA Oversight Added To GAO’s “High Risk” List

The Government Accountability Office has added enhanced oversight of devices, drugs and other medical products to its list of "high risk" priorities

FY 2009 Approps Package Will Likely Need To Wait For Next Administration

House Democratic leaders are signaling an intention to put off finalizing fiscal 2009 appropriations at least until next March, charging Republican members of Congress and the Bush administration are impeding negotiations on mutually agreeable bills

FDA Expects Greater Scientific Impact With Larger Advisory Board

FDA Commissioner Andrew von Eschenbach is attempting to increase the impact of the agency's Science Board Advisory Committee by doubling the number of members and meetings

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel